Adipose-derived stem cells in orthopaedic pathologies

Federico Giuseppe Usuelli, Riccardo D'Ambrosi, Camilla Maccario, Cristian Indino, Luigi Manzi, Nicola Maffulli

Research output: Contribution to journalReview article

Abstract

Introduction To examine the current literature regarding the clinical application of adipose-derived stem cells (ADSCs) for the management of orthopaedic pathologies Sources of data MEDLINE,SCOPUS, CINAHL and EMBASE (1950 to April 14, 2017) were searched by two independent investigators for articles published in English. Reviews, meta-analyses, expert opinions, case reports, mini case series and editorials were excluded. Furthermore, we excluded animal studies, cadaveric studies and in vitro studies. Areas of agreement ADSCs seem to produce excellent clinical results. However, the length and modalities of follow-up in the different conditions are extremely variable. Nevertheless, it appears that the use of adipose-derived stem cells is associated with subjective and objective clinical improvements and minimal complication rates. Areas of controversy None of the studies identified is a randomized double-blinded trial, and most of the selected studies present major limitations, and different methods, confounding the results of our review. Growing points It is necessary to conduct more and better studies to ascertain whether ADSCs really play a role in orthopaedic surgery with particular attention to ADSCs harvesting method, type of administration and the conditions treated. Areas timely for developing research The current literature regarding the use of ADSCs for orthopaedic pathologies is limited. At present, long-term safety is the biggest challenge of ADSCs based regenerative medicine. Level of evidence Level IV-Study of Level I, II, III, IV

Original languageEnglish
Pages (from-to)31-54
Number of pages24
JournalBritish Medical Bulletin
Volume124
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Orthopedics
Stem Cells
Pathology
Regenerative Medicine
Information Storage and Retrieval
Expert Testimony
MEDLINE
Meta-Analysis
Research Personnel
Safety
Research

Keywords

  • adipose-derived stem cells
  • injection
  • mesenchymal stem cells
  • PRP
  • regenerative medicine
  • scaffold
  • stromal vascular fraction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Usuelli, F. G., D'Ambrosi, R., Maccario, C., Indino, C., Manzi, L., & Maffulli, N. (2017). Adipose-derived stem cells in orthopaedic pathologies. British Medical Bulletin, 124(1), 31-54. https://doi.org/10.1093/bmb/ldx030

Adipose-derived stem cells in orthopaedic pathologies. / Usuelli, Federico Giuseppe; D'Ambrosi, Riccardo; Maccario, Camilla; Indino, Cristian; Manzi, Luigi; Maffulli, Nicola.

In: British Medical Bulletin, Vol. 124, No. 1, 01.12.2017, p. 31-54.

Research output: Contribution to journalReview article

Usuelli, FG, D'Ambrosi, R, Maccario, C, Indino, C, Manzi, L & Maffulli, N 2017, 'Adipose-derived stem cells in orthopaedic pathologies', British Medical Bulletin, vol. 124, no. 1, pp. 31-54. https://doi.org/10.1093/bmb/ldx030
Usuelli FG, D'Ambrosi R, Maccario C, Indino C, Manzi L, Maffulli N. Adipose-derived stem cells in orthopaedic pathologies. British Medical Bulletin. 2017 Dec 1;124(1):31-54. https://doi.org/10.1093/bmb/ldx030
Usuelli, Federico Giuseppe ; D'Ambrosi, Riccardo ; Maccario, Camilla ; Indino, Cristian ; Manzi, Luigi ; Maffulli, Nicola. / Adipose-derived stem cells in orthopaedic pathologies. In: British Medical Bulletin. 2017 ; Vol. 124, No. 1. pp. 31-54.
@article{2fefb109a7ce49e38e4d273125b4b084,
title = "Adipose-derived stem cells in orthopaedic pathologies",
abstract = "Introduction To examine the current literature regarding the clinical application of adipose-derived stem cells (ADSCs) for the management of orthopaedic pathologies Sources of data MEDLINE,SCOPUS, CINAHL and EMBASE (1950 to April 14, 2017) were searched by two independent investigators for articles published in English. Reviews, meta-analyses, expert opinions, case reports, mini case series and editorials were excluded. Furthermore, we excluded animal studies, cadaveric studies and in vitro studies. Areas of agreement ADSCs seem to produce excellent clinical results. However, the length and modalities of follow-up in the different conditions are extremely variable. Nevertheless, it appears that the use of adipose-derived stem cells is associated with subjective and objective clinical improvements and minimal complication rates. Areas of controversy None of the studies identified is a randomized double-blinded trial, and most of the selected studies present major limitations, and different methods, confounding the results of our review. Growing points It is necessary to conduct more and better studies to ascertain whether ADSCs really play a role in orthopaedic surgery with particular attention to ADSCs harvesting method, type of administration and the conditions treated. Areas timely for developing research The current literature regarding the use of ADSCs for orthopaedic pathologies is limited. At present, long-term safety is the biggest challenge of ADSCs based regenerative medicine. Level of evidence Level IV-Study of Level I, II, III, IV",
keywords = "adipose-derived stem cells, injection, mesenchymal stem cells, PRP, regenerative medicine, scaffold, stromal vascular fraction",
author = "Usuelli, {Federico Giuseppe} and Riccardo D'Ambrosi and Camilla Maccario and Cristian Indino and Luigi Manzi and Nicola Maffulli",
year = "2017",
month = "12",
day = "1",
doi = "10.1093/bmb/ldx030",
language = "English",
volume = "124",
pages = "31--54",
journal = "British Medical Bulletin",
issn = "0007-1420",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Adipose-derived stem cells in orthopaedic pathologies

AU - Usuelli, Federico Giuseppe

AU - D'Ambrosi, Riccardo

AU - Maccario, Camilla

AU - Indino, Cristian

AU - Manzi, Luigi

AU - Maffulli, Nicola

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Introduction To examine the current literature regarding the clinical application of adipose-derived stem cells (ADSCs) for the management of orthopaedic pathologies Sources of data MEDLINE,SCOPUS, CINAHL and EMBASE (1950 to April 14, 2017) were searched by two independent investigators for articles published in English. Reviews, meta-analyses, expert opinions, case reports, mini case series and editorials were excluded. Furthermore, we excluded animal studies, cadaveric studies and in vitro studies. Areas of agreement ADSCs seem to produce excellent clinical results. However, the length and modalities of follow-up in the different conditions are extremely variable. Nevertheless, it appears that the use of adipose-derived stem cells is associated with subjective and objective clinical improvements and minimal complication rates. Areas of controversy None of the studies identified is a randomized double-blinded trial, and most of the selected studies present major limitations, and different methods, confounding the results of our review. Growing points It is necessary to conduct more and better studies to ascertain whether ADSCs really play a role in orthopaedic surgery with particular attention to ADSCs harvesting method, type of administration and the conditions treated. Areas timely for developing research The current literature regarding the use of ADSCs for orthopaedic pathologies is limited. At present, long-term safety is the biggest challenge of ADSCs based regenerative medicine. Level of evidence Level IV-Study of Level I, II, III, IV

AB - Introduction To examine the current literature regarding the clinical application of adipose-derived stem cells (ADSCs) for the management of orthopaedic pathologies Sources of data MEDLINE,SCOPUS, CINAHL and EMBASE (1950 to April 14, 2017) were searched by two independent investigators for articles published in English. Reviews, meta-analyses, expert opinions, case reports, mini case series and editorials were excluded. Furthermore, we excluded animal studies, cadaveric studies and in vitro studies. Areas of agreement ADSCs seem to produce excellent clinical results. However, the length and modalities of follow-up in the different conditions are extremely variable. Nevertheless, it appears that the use of adipose-derived stem cells is associated with subjective and objective clinical improvements and minimal complication rates. Areas of controversy None of the studies identified is a randomized double-blinded trial, and most of the selected studies present major limitations, and different methods, confounding the results of our review. Growing points It is necessary to conduct more and better studies to ascertain whether ADSCs really play a role in orthopaedic surgery with particular attention to ADSCs harvesting method, type of administration and the conditions treated. Areas timely for developing research The current literature regarding the use of ADSCs for orthopaedic pathologies is limited. At present, long-term safety is the biggest challenge of ADSCs based regenerative medicine. Level of evidence Level IV-Study of Level I, II, III, IV

KW - adipose-derived stem cells

KW - injection

KW - mesenchymal stem cells

KW - PRP

KW - regenerative medicine

KW - scaffold

KW - stromal vascular fraction

UR - http://www.scopus.com/inward/record.url?scp=85040041133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040041133&partnerID=8YFLogxK

U2 - 10.1093/bmb/ldx030

DO - 10.1093/bmb/ldx030

M3 - Review article

AN - SCOPUS:85040041133

VL - 124

SP - 31

EP - 54

JO - British Medical Bulletin

JF - British Medical Bulletin

SN - 0007-1420

IS - 1

ER -